Cargando…
Practice change in the management of metastatic urothelial carcinoma after ASCO 2020
Metastatic urothelial carcinoma (mUC) is an incurable and aggressive disease. In the past decades there have been few effective treatment options that have impacted the prognosis of mUC patients. However, in the last few years, several drugs have emerged as new treatment choices that are changing th...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7769717/ https://www.ncbi.nlm.nih.gov/pubmed/33437659 http://dx.doi.org/10.5306/wjco.v11.i12.976 |